RUO Peptides Explained: Are Peptides Steroids, and Which Peptides Are FDA-Approved?

Peptides, including RUO peptides, are not steroids: a peptide is a short chain of amino acids, while a steroid is a molecule built on four fused carbon rings [R1][R2]. More than 80 peptide drugs have reached the market worldwide [R3], but the many peptides sold online as “research use only” (RUO) are not among them. This guide answers the questions people are searching for this week, with a source for every claim.

What Is a Peptide?

A peptide is a short chain of amino acids joined by peptide bonds. The U.S. National Human Genome Research Institute describes peptides as chains of roughly 2 to 50 amino acids; longer chains are polypeptides, and proteins are made of one or more polypeptides [R1]. The cutoff is a convention, not a rule: some authorities place the line between peptide and protein closer to 100 amino acids [R4].

What Do Peptides Do?

In the body, many peptides act as signaling molecules. Insulin is the best-known example: a peptide hormone, and in 1982 the recombinant human version, Humulin, became the first recombinant-DNA protein drug approved for human use [R5]. In research, synthetic peptides are used to study how these signals bind receptors and change cell behavior.

Are Peptides Steroids?

No. The two belong to different chemical classes. A steroid has a core of 17 carbon atoms arranged in four rings; cholesterol, cortisol, and androgens are examples [R2]. Anabolic steroids are synthetic versions of testosterone [R6]. A peptide’s backbone is a chain of amino acids (some peptides are cyclized), not a four-ring carbon skeleton [R1].

Sources: [R1][R2][R6]

What Peptides Are FDA-Approved?

More than 80 peptide drugs have been approved worldwide since insulin, and over 170 more are in clinical development [R3][R7]. These are some of the best-known U.S. approvals:

Which Peptides Are FDA-Approved for Weight Management?

Of the drugs above, three are approved specifically for chronic weight management: liraglutide (Saxenda, 2014), semaglutide (Wegovy, 2021), and tirzepatide (Zepbound, 2023) [R10][R13][R15]. These are prescription medicines made under FDA oversight, which is different from research-grade material sold online.

Is Retatrutide FDA-Approved?

No. Retatrutide (LY3437943) is an investigational compound. Its developer has reported phase 3 results and plans to submit a Biologics License Application to the FDA in the first quarter of 2027, and states that retatrutide cannot legally be sold for human use [R16]. In March 2025, FDA told state medical boards that compounded retatrutide does not qualify for the legal exemptions that allow compounding [R17].

Is CJC-1295 FDA-Approved?

No. CJC-1295 is a long-acting analog of growth hormone-releasing hormone that was tested in two small placebo-controlled studies in healthy adults in 2006 [R18]. It has never been approved as a drug. In December 2024, FDA’s compounding advisory committee voted against adding any form of CJC-1295 to the list of substances pharmacies may compound from [R19]. FDA’s safety-risk list, where CJC-1295 appeared before its nomination was withdrawn, cites immunogenicity, impurity characterization, and serious adverse events including increased heart rate [R20].

What Does “Research Use Only” (RUO) Mean?

“Research Use Only” is a formal FDA label for in vitro diagnostic products in the laboratory research phase; the required wording is “For Research Use Only. Not for use in diagnostic procedures” [R21]. FDA’s guidance says the label alone does not settle a product’s status; the agency looks at the totality of circumstances [R21].

FDA applies the same logic to peptides. In 2026 warning letters, it treated peptides labeled “research use only” as unapproved drugs where a seller’s website showed they were intended for people, citing disclaimers that did not match how the products were marketed [R22][R23]. RUO peptides are meant for laboratory research by qualified researchers, not for human use.

Are There “Licensed,” “Certified,” or “Verified” Research Peptides?

Not in a regulatory sense. FDA approves drugs, not research chemicals, and registering a facility or listing a product does not mean FDA approval [R24]. Laboratory accreditation such as ISO/IEC 17025 shows a testing lab is competent; it does not certify the product being tested [R25]. What a buyer of research material can check is evidence: a batch-specific certificate of analysis with HPLC purity and mass-spectrometry identity. See our guide on how to read a peptide COA.

Frequently Asked Questions

Are peptides steroids?

No. Peptides are chains of amino acids; steroids are four-ring molecules such as cortisol and testosterone [R1][R2].

What peptides are FDA-approved?

More than 80 peptide drugs are approved worldwide (not all in the U.S.), including insulin, octreotide, liraglutide, semaglutide, and tirzepatide [R3].

What are RUO peptides?

Peptides sold labeled “research use only,” intended for laboratory research. The label does not make a product FDA-approved, and FDA judges intended use from how a product is marketed [R22].

Is retatrutide approved?

No. It is investigational, with an FDA submission planned for early 2027 [R16].

Related research guides

How to read a peptide certificate of analysis · Epitalon vs Epithalon vs Epithalamin

References

How we select and verify sources: Research Sources & Editorial Standards

1. National Human Genome Research Institute. Peptide. Talking Glossary of Genomic and Genetic Terms. genome.gov
2. Encyclopaedia Britannica. Steroid. britannica.com
3. Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021;20(4):309–325. doi:10.1038/s41573-020-00135-8. PMID 33536635.
4. Encyclopaedia Britannica. Peptide. britannica.com
5. Riggs AD. Making, cloning, and the expression of human insulin genes in bacteria: the path to Humulin. Endocr Rev. 2021;42(3):374–380. doi:10.1210/endrev/bnaa029. PMID 33340315.
6. MedlinePlus, U.S. National Library of Medicine. Anabolic steroids. medlineplus.gov
7. Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7:48. doi:10.1038/s41392-022-00904-4. PMID 35165272.
8. U.S. FDA. Drugs@FDA: Sandostatin (octreotide), NDA 019667. accessdata.fda.gov
9. U.S. FDA. Drugs@FDA: Victoza (liraglutide), NDA 022341. accessdata.fda.gov
10. U.S. FDA. Drugs@FDA: Saxenda (liraglutide), NDA 206321. accessdata.fda.gov
11. U.S. FDA. Drugs@FDA: Egrifta (tesamorelin), BLA 022505. accessdata.fda.gov
12. U.S. FDA. Drugs@FDA: Ozempic (semaglutide), NDA 209637. accessdata.fda.gov
13. U.S. FDA. FDA approves new drug treatment for chronic weight management, first since 2014 (Wegovy). June 4, 2021. Reprinted at biospace.com
14. U.S. FDA. FDA approves novel, dual-targeted treatment for type 2 diabetes (Mounjaro). May 13, 2022. Reprinted at biospace.com
15. U.S. FDA. FDA approves new medication for chronic weight management (Zepbound). November 8, 2023. fda.gov
16. Retatrutide developer. Triple agonist retatrutide: TRIUMPH-2 topline results. Press release, September 29, 2026. Press release
17. Gozun E, U.S. FDA CDER. Letter to the Federation of State Medical Boards on retatrutide. March 31, 2025. PDF
18. Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799–805. doi:10.1210/jc.2005-1536. PMID 16352683.
19. U.S. FDA. Pharmacy Compounding Advisory Committee, December 4, 2024: final summary minutes. fda.gov
20. U.S. FDA. Certain bulk drug substances for use in compounding that may present significant safety risks. fda.gov
21. U.S. FDA. Distribution of in vitro diagnostic products labeled for research use only or investigational use only. Guidance, November 25, 2013. PDF
22. U.S. FDA. Warning letter: Gram Peptides, MARCS-CMS 721806. March 31, 2026. fda.gov
23. U.S. FDA. Warning letter: TXP Innovations LLC dba Tex Peptides, MARCS-CMS 735067. August 24, 2026. fda.gov
24. U.S. FDA. Is it really “FDA approved”? Consumer update. fda.gov
25. National Institute of Standards and Technology. About NVLAP. nist.gov

This article summarizes published research and public regulatory documents for educational purposes. Sequora Peptides supplies research chemicals for laboratory use only; nothing here describes use in humans or animals. Sequora Peptides is not affiliated with any drug manufacturer.

For laboratory research use only. Not for human or veterinary use.